Titre
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Auteur(s)
Cibula, D.
Auteure/Auteur
Raspollini, M.R.
Auteure/Auteur
Planchamp, F.
Auteure/Auteur
Centeno, C.
Auteure/Auteur
Chargari, C.
Auteure/Auteur
Felix, A.
Auteure/Auteur
Fischerová, D.
Auteure/Auteur
Jahnn-Kuch, D.
Auteure/Auteur
Joly, F.
Auteure/Auteur
Kohler, C.
Auteure/Auteur
Lax, S.
Auteure/Auteur
Lorusso, D.
Auteure/Auteur
Mahantshetty, U.
Auteure/Auteur
Mathevet, P.
Auteure/Auteur
Naik, R.
Auteure/Auteur
Nout, R.A.
Auteure/Auteur
Oaknin, A.
Auteure/Auteur
Peccatori, F.
Auteure/Auteur
Persson, J.
Auteure/Auteur
Querleu, D.
Auteure/Auteur
Bernabé, S.R.
Auteure/Auteur
Schmid, M.P.
Auteure/Auteur
Stepanyan, A.
Auteure/Auteur
Svintsitskyi, V.
Auteure/Auteur
Tamussino, K.
Auteure/Auteur
Zapardiel, I.
Auteure/Auteur
Lindegaard, J.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1525-1438
Statut éditorial
Publié
Date de publication
2023-05-01
Volume
33
Numéro
5
Première page
649
Dernière page/numéro d’article
666
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Publication Status: epublish
Résumé
In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of patients with cervical cancer. Given the large body of new evidence addressing the management of cervical cancer, the three sister societies jointly decided to update these evidence-based guidelines. The update includes new topics to provide comprehensive guidelines on all relevant issues of diagnosis and treatment in cervical cancer.To serve on the expert panel (27 experts across Europe) ESGO/ESTRO/ESP nominated practicing clinicians who are involved in managing patients with cervical cancer and have demonstrated leadership through their expertise in clinical care and research, national and international engagement, profile, and dedication to the topics addressed. To ensure the statements were evidence based, new data identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the international development group. Before publication, the guidelines were reviewed by 155 independent international practitioners in cancer care delivery and patient representatives.These updated guidelines are comprehensive and cover staging, management, follow-up, long-term survivorship, quality of life and palliative care. Management includes fertility sparing treatment, early and locally advanced cervical cancer, invasive cervical cancer diagnosed on a simple hysterectomy specimen, cervical cancer in pregnancy, rare tumors, recurrent and metastatic diseases. The management algorithms and the principles of radiotherapy and pathological evaluation are also defined.
PID Serval
serval:BIB_650EF4DE1A4C
PMID
Open Access
Oui
Date de création
2023-05-08T09:32:08.337Z
Date de création dans IRIS
2025-05-20T22:21:37Z
Fichier(s)![Vignette d'image]()
En cours de chargement...
Nom
37127326_BIB_650EF4DE1A4C.pdf
Version du manuscrit
published
Licence
https://creativecommons.org/licenses/by/4.0
Taille
3.29 MB
Format
Adobe PDF
PID Serval
serval:BIB_650EF4DE1A4C.P001
URN
urn:nbn:ch:serval-BIB_650EF4DE1A4C9
Somme de contrôle
(MD5):ac840f6d7632b8dce61e1fd176e21ac1